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Background: The use of assisted conception (AC) has been associated with higher risk of adverse perinatal
outcome. Few data are available on the outcome of AC-neonates when pregnancy ends before 32 weeks of
gestational age.
The aim of this study was to compare the short-term outcome of AC- and naturally conceived preterm infants <32 weeks
gestation.
Methods: The area-based cohort study ACTION collected data on births 22-31 weeks gestation occurred in 2003-05 in 6
Italian regions. Infants born to 2529 mothers with known mode of conception were studied. The main outcomes were
hospital mortality and survival free from major morbidities (IVH grade 3-4, cPVL, ROP stage ≥3, BPD), and were assessed
separately for single and multiple infants. Other outcomes were also investigated. Multivariable logistic analyses were
used to adjust for maternal and infants’ characteristics. To account for the correlation of observations within intensive
care units, robust variance and standard error estimates of regression parameters were computed.
Results: AC was used in 6.4% of mothers. Infants were 2934; 314 (10.7%) were born after AC. Multiples were 86.0%
among AC and 21.7% among non-AC babies. In multivariable analysis no statistically significant difference in hospital
mortality and survival without major morbidities was found between AC and non-AC infants. The risk of BPD was lower
in AC than in non-AC multiples (aOR 0.41, CI 0.20-0.87), and this finding did not change after controlling for mechanical
ventilation (aOR 0.42, CI 0.20-0.85) or presence of a patent ductus arteriosus (aOR 0.39, CI 0.18-0.84).
Conclusion: When the analysis is restricted to very preterm infants and stratified by multiplicity, no significant
associations between AC and increased risk of short-term mortality and survival without major morbidities emerge. This
result is consistent with previous studies, and may confirm the hypothesis that the adverse effects of AC are mediated
by preterm birth. However, larger appropriately powered studies are needed before definitely excluding the possibility of
adverse events linked to AC in infants born before 32 weeks gestation.
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Births after Assisted Conception (AC) have increased in
the last decades in industrialized countries, currently ac-
counting for over 1% of all livebirths in the USA, nearly
2% in Italy and UK, and up to 6% in other European
countries [1-3]. As a consequence, concerns have been
raised about possible increased risks of adverse preg-
nancy and infant outcomes, in particular after the use of
assisted reproductive technologies (ART) that involve
gamete manipulation outside the reproductive systems.
Multiple pregnancy, placenta praevia, antepartum haem-
orrhage, incompetent cervix, pregnancy-induced hyper-
tension, preterm birth, low birth weight, foetal growth
restriction, birth defects, caesarean delivery, and admis-
sion of newborn babies to neonatal intensive care unit
(NICU) have been reported [4-7]. Risks appear to be higher
in single compared to multiple births [8,9]. Open issues
still remain, mainly related to the potential confounding ef-
fects of maternal sociodemographic characteristics and life-
styles, the possibility of spontaneous reduction in case of
multifoetal pregnancy, the effect of infertility “per se” and
of the different technical approaches adopted [4].
Most of the adverse neonatal outcomes after AC are
linked to the increased risk of prematurity. When the ana-
lysis was restricted to infants born before 32 weeks gestation
(Very Preterm Infants, VPI) or with birth weight <1500 g
(Very Low Birth Weight Infants, VLBWI), no excess mortal-
ity and morbidity linked to AC was found [10-15]; nor there
was an increased emotional burden in mothers after AC
during the neonatal period [16]. However, with the excep-
tion of one area-based [12] and one multi-centre hospital
based [10] studies, most of the evidence is derived from
retrospective single-centre investigations [11,13-16].
In this study we used the data of a large area-based
prospective cohort study aiming at comparing the neo-
natal outcomes of AC- and naturally conceived VPI, sep-
arately for singletons and multiples.
Methods
Study population
The ACTION (Accesso alle Cure e Terapie Intensive
Ostetriche e Neonatali ) project was a prospective area-
based cohort study carried out in 6 Italian regions: two in
the North (Lombardia and Friuli Venezia-Giulia), three in
the Centre (Toscana, Marche and Lazio) and one in the
South of Italy (Calabria). Overall, about 40% of all Italian
births take place in these regions.
All mothers of infants born at 22 to 31 completed
weeks of gestational age (GA) and admitted to NICU be-
tween July 2003 and December 2004 in Lombardia,
Lazio and Calabria, and up to June 2005 in Friuli
Venezia-Giulia, Tuscany and Marche were enrolled in
the study (n = 2660). Infants were followed up to dis-
charge from hospital or death in NICU.The study was approved by the Paediatric Ethics Com-
mittee of Tuscany, that was the project-leader region.
Parental written informed consent was obtained.Data collection
A standardized form was used to collect information on
mothers’ characteristics, pregnancy complications and
care, babies’ conditions and assistance at birth, morbid-
ities and treatments in the NICU, outcome at discharge
from hospital. Assisted conception was defined as any
kind of treatment for infertility, including techniques
that assist the egg fertilization and implantation. GA was
recorded, in completed weeks and days, as the best ob-
stetrical estimate using information on the last men-
strual period and ultrasound measures. According to the
Italian guidelines, the ultrasound GA estimate was used
instead of that based on the date of the last menstrual
period when the difference between the two was ≥1 week
and the ultrasound evaluation was performed within
16 weeks gestation [17]. The level of centre of birth was
defined as tertiary when a 3rd level NICU was present in
the same hospital. Complications in pregnancy were de-
fined according to the MOSAIC study [18], and grouped
into a) disorders of placentation, including pregnancy
hypertension disorders, HELLP syndrome, pre-eclampsia,
eclampsia, and foetal growth restriction, and b) intrauter-
ine inflammation/infection, including threatened preterm
birth, preterm premature rupture of membranes, antepar-
tum haemorrhage and maternal infection [19]. Small for
gestational age (SGA) infants were those whose birth
weight was below the 10th percentile, derived from this
same cohort by week of gestation and sex. We used the
10th percentile cutoff because it is the most frequently
quoted in the literature, and was adopted in other area-
based European research projects [18,20,21].
Main infants’ outcomes were defined as death before
discharge and survival without major morbidities. The
last included: intraventricular haemorrhage (IVH, grade
3-4) [22], cystic periventricular leukomalacia (c-PVL,
grade 2-4) [23], retinopathy of prematurity (ROP, stage ≥3),
and bronchopulmonary dysplasia (BPD, defined as need for
oxygen supplementation at 36 weeks GA or at discharge
for infants discharged earlier). Other outcomes were ultra-
sound diagnosed patent ductus arteriosus (PDA), necrotiz-
ing enterocolitis (NEC stage 2 or 3, modified Bell’s criteria)
[24], any sepsis or meningitis (clinical and hematological
signs ± positive culture), length of hospitalization for survi-
vors, and any breastfeeding at discharge.Statistical analysis
Single and multiple infants were considered separately.
Univariate chi-squared or t test calculation were used
as appropriate to explore the relationships between AC
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and infants’ variables.
Multivariable logistic regression models were used to
assess the association between AC and infant outcomes,
adjusting for potential confounders. Robust variance and
standard error estimates of regression parameters were
calculated using the clustered sandwich estimator method,
to account for the intra-group correlation of observations
within NICUs [25]. The following variables were controlled
for: gender, any antenatal steroids, GA in completed weeks,
SGA status, mode of delivery, region of birth and maternal
variables. These included maternal age (coded as <35
or ≥35 years), country of origin (Italy or otherwise),
education (primary/lower secondary versus upper sec-
ondary/university), and any previous births (yes or no).
Missing data in the explanatory variables were included in
the models as dummies. Missing values were always ≤ 5%,
with the exception of maternal age and education (missing
7% and 14% respectively).
Results are presented in tables as absolute and relative
frequencies, and as adjusted odds ratios (aOR) and 95%
confidence intervals (CI). Frequencies of neonatal mor-
bidities were computed on infants surviving to diagnos-
tic ascertainment, or to 36 weeks GA age for BPD.
The STATA software, version 10 (StataCorp 2007.
Stata statistical software: Release 10. College Station, TX:
StataCorp) was used for statistical analyses. Power ana-









Figure 1 Description of the cohort under study.the PASS 13 software (NCSS, LLC, Kaysville, Utah,
USA) [26].
Data were reported and discussed according to the
STROBE statement checklist for observational cohort
studies (www.strobe-statement.org) (Additional file 1).
Results
One hundred and thirty one mothers (4.9%) were excluded
because mode of conception was unknown (Figure 1). AC
was employed in 163 of the remaining 2529 mothers
(6.4%). Details about the technique used were available for
113 births: in vitro fertilization (IVF) or intracytoplasmic
sperm injection (ICSI) was used in 68% of them. The over-
all frequency of multiple births was 16.1% (n = 407): 73.0%
(n = 119) in AC group and 12.2% (n = 288) in non-AC
group. Liveborn infants were 2934 (314 following AC,
10.7%); 27.7% of them were multiples (n = 812), and 72.3%
were singletons (n = 2122).
AC use was significantly more frequent when mothers
were older and more educated, and less frequent in for-
eign mothers and after previous births (Table 1). No statis-
tically significant differences in pregnancy complications,
GA distribution and administration of antenatal steroids
were found between non-AC and AC pregnancies. Twin,
triplet and quadruplet births were more frequent follow-
ing AC. Mothers with AC pregnancies were more likely to
have a spontaneous onset of labour, be delivered in a ter-











Table 1 Maternal, pregnancy and delivery variables, by mode of conception (n = 2529)
Non-AC AC p-value
n (%) n (%)
Age ≥35 years 703 (31.9) 69 (45.4) <0.001
Country of origin other than Italy 541 (23.2) 16 (9.9) <0.001
Upper secondary/university education 1206 (59.6) 108 (78.3) <0.001
Previous births 937 (40.4) 30 (18.5) <0.001
Plurality
Twin 264 (11.6) 75 (46.0)
Triplet 14 (0.6) 42 (25.8) <0.001
Quadruplet 0 2 (1.2)
Complications of pregnancy
Disorders of placentation1 731 (31.4) 46 (28.4) 0.431
Inflammation/infection2 1446 (61.9) 109 (67.3) 0.170
Gestational age at delivery (weeks)
<26 345 (14.6) 28 (17.2) 0.606
26-27 412 (17.4) 23 (14.1)
28-29 591 (25.0) 39 (23.9)
30-31 1018 (43.0) 73 (44.8)
Delivery at tertiary centre 2108 (89.1) 154 (94.5) 0.031
Any antenatal steroids 1741 (76.4) 131 (81.9) 0.111
Spontaneous onset of labour 1014 (43.8) 84 (52.8) 0.027
Caesarean delivery 1687 (71.6) 130 (79.7) 0.025
1Disorders of placentation include: pregnancy hypertension disorders, HELLP syndrome, pre-eclampsia, eclampsia, foetal growth restriction.
2Inflammation/infection disorders include: threatened preterm labor, PPROM, antepartum haemorrhage, maternal infection.
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mode of conception are shown in Table 2. Females were
more frequent among AC singletons. Frequencies of
mechanical ventilation, PDA, and BPD were lower in
AC compared to non-AC multiples. A shorter length of
hospitalization was observed in surviving AC multiples.
In multivariable analyses (Table 3), the aOR point esti-
mates for hospital mortality and survival without major
morbidities were 1.60 and 0.75 respectively in singletons,
and 0.79 and 1.30 in multiples. The associations were
not significant as all the CIs included unity. However,
the statistical power estimates were low, ranging from
0.23 for mortality and 0.13 for survival without major
morbidities in singletons, and 0.13 and 0.25 for the two
outcomes, respectively, in multiples. We cannot there-
fore exclude that a much larger study might have led to
statistically significant results.
Similar non-significant differences were found for the
other morbidity outcomes in singletons, although in
some cases the aOR point estimates were well above 2
(severe IVH) or below 0.5 (sepsis/meningitis). Among
multiples, however, statistically significant lower risks for
PDA (aOR 0.64, CI 0.45-0.90) and BPD (aOR 0.41, CI
0.20-0.87) were found, while for NEC the decreased risk
(aOR 0.44, CI 0.19-1.02) was at borderline significance.The association between AC and PDA in multiples
remained statistically significant after adjustment for
mechanical ventilation (aOR 0.68, CI 0.48-0.97), and that
with BPD did not change after controlling for ventilation
or PDA, (aORs 0.42, CI 0.20-0.85, and 0.39, CI 0.18-
0.84, respectively).
Discussion
In this area-based cohort of very preterm infants we
could not demonstrate clear differences in mortality and
survival without major morbidities between naturally
and AC-conceived babies.
To some extent our findings are comparable to those
of previous studies in very preterm or VLBWI. Stewart
et al. [10] studied 1473 VLBWI, and found no difference
in cranial ultrasound abnormalities between naturally
conceived babies and those born after ART or use of fer-
tility therapy. In multiple VLBWI Hashimoto et al. [11]
found no difference in mortality, BPD, and the combined
outcome mortality or BDP between naturally conceived
babies and those conceived following fertility treatment.
In a large population of VLBWI, Schimmel et al. [12]
found no difference in mortality, respiratory distress syn-
drome, PDA, NEC, IVH, BPD, and congenital malforma-
tions between babies born after IVF (n = 1396) and those
Table 2 Infants’ characteristics and short term outcomes by plurality and mode of conception (n = 2934)
Singletons Multiples
Non-AC (n = 2078) AC (n = 44) p value Non-AC (n = 542) AC (n = 270) p value
n (%) n (%) n (%) n (%)
Gender, females 944 (45.5) 27 (61.4) 0.036 255 (47.0) 128 (47.4) 0.923
SGA 217 (10.5) 6 (13.6) 0.498 41 (7.6) 16 (6.0) 0.393
Malformations
Lethal 2 (0.1) 0 0 0 0.265
Acutely life-threatening 35 (1.8) 0 0.790 4 (0.8) 0
Non acutely life-threatening 105 (5.3) 3 (7.1) 23 (4.4) 8 (3.1)
Apgar score <7/ intubated at 5 m’ 965 (47.1) 23 (52.3) 0.500 218 (40.7) 101 (38.1) 0.474
CRIB score
>2 773 (41.4) 17 (41.5) 0.758 158 (32.8) 77 (32.8) 0.777
not attributed 213 (13.2) 3 (6.8) 61 (11.2) 35 (13.0)
Any surfactant 1164 (57.3) 29 (69.0) 0.129 300 (56.7) 139 (53.0) 0.330
nCPAP 1462 (72.3) 33 (78.6) 0.368 357 (68.3) 167 (64.2) 0.259
Mechanical ventilation 1272 (62.7) 31 (72.1) 0.205 316 (60.3) 138 (52.5) 0.036
PDA 798 (42.5) 20 (55.6) 0.116 243 (50.7) 101 (42.8) 0.046
NEC 69 (3.5) 0 0.226 20 (3.8) 6 (2.4) 0.286
Sepsis/meningitis 442 (21.8) 7 (16.7) 0.425 106 (20.0) 48 (18.4) 0.591
IVH grade 3 or 4 166 (8.5) 6 (14.3) 0.188 52 (10.3) 25 (9.9) 0.865
c-PVL 99 (5.1) 0 0.142 32 (6.23) 12 (4.8) 0.393
ROP stage ≥3 79 (4.3) 1 (2.9) 0.676 17 (3.7) 5 (2.1) 0.280
BPD 219 (12.7) 6 (17.1) 0.433 44 (10.1) 9 (4.2) 0.010
Death before discharge 364 (17.6) 9 (20.9) 0.566 110 (20.4) 52 (19.3) 0.709
Survival without major morbidities1 1356 (65.4) 26 (60.5) 0.500 363 (67.2) 191 (70.7) 0.310
Any breast feeding at discharge 1001 (59.8) 23 (74.2) 0.105 255 (61.3) 135 (63.4) 0.611
Lenght of stay, survivors Days, mean (sd) 64.6 (34.3) 61.9 (31.2) 0.6532 60.2 (33.2) 54.5 (27.7) 0.0312
SGA: Small for gestational age; nCPAP: Nasal continuous positive airway pressure; PDA: Patent ductus arteriosus; NEC: Necrotizing enterocolitis; IVH: Intraventricular
haemorrhage; c-PVL: Cystic periventricular leukomalacia; ROP: Retinopathy of prematurity; BPD: Bronchopulmonary dysplasia. Frequencies of morbidities were
computed on babies who survived to have the relevant diagnostic ascertainment or up to 36 weeks GA for BPD.
1Major morbidities defined as: IVH grade 3-4, c-PVL, ROP stage ≥3, BPD.
2t test.
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compared 195 VLBWI born after IVF with 1228 natur-
ally conceived VLBWI, and found no difference in mor-
tality, short term pulmonary morbidity, severe cerebral
morbidity and frequency of SGA babies. Shah et al.
[14] compared the neonatal outcome of 137 multiple
infants ≤32 weeks GA born after ART with that of 233
naturally conceived multiple babies with similar GA,
and found no difference in outcome defined as a com-
bination of death, grade 3/4 IVH or periventricular leuko-
malacia, ROP stage >2, and chronic lung disease. Picaud
et al. [15] reported survival without severe morbidity in
612 infants <33 weeks GA: 81 were born following ART and
521 were naturally conceived. Using a composite morbidity
index based on the occurrence of NEC, IVH grade ≥3, peri-
ventricular leukomalacia, and BPD, these authors found that
survival without severe morbidity was higher in ART infants.Most of the unfavourable neonatal outcomes reported
when also moderate/late preterm and term infants are
included in the study populations are probably the con-
sequence of the shift of GA distribution toward lower
values; this shift is predominantly related to the higher
frequency of multiplicity, but it was observed also in sin-
gle pregnancies [4,8,27-29]. Causes of infertility, in ad-
junct to and independently from factors related to the
reproductive technology itself, may also contribute to the
unfavorable outcomes associated with AC [30]. However,
when only very preterm or very low birth weight infants
are considered, the effect of multiplicity on gestational age
does not apply, and both AC- and naturally conceived in-
fants are exposed to the adverse influence of very early
birth and immaturity of organs. Additionally, AC pregnan-
cies may benefit from the better prenatal and perinatal
care associated with medically assisted reproduction,
Table 3 Adjusted odds ratios (aOR) of neonatal morbidity
and mortality outcomes comparing AC and non-AC babies,
separately for singletons and multiples
Singletons Multiples
aOR1 95% CI aOR1 95% CI
PDA 1.63 0.84-3.16 0.64 0.45-0.90
IVH, grade 3-4 2.40 0.93-6.19 1.08 0.52-2.23
c-PVL - 2 - 1.09 0.46-2.58
IVH grade 3-4 or c-PVL 1.36 0.59-3.14 1.00 0.55-1.81
Sepsis/meningitis 0.48 0.20-1.17 0.89 0.53-1.47
NEC - 2 - 0.44 0.19-1.02
ROP, stage ≥3 0.57 0.06-5.51 0.36 0.11-1.15
BPD 1.37 0.58-3.23 0.41 0.20-0.87
Death before discharge 1.60 0.72-3.54 0.79 0.47-1.33
Survival without major morbidities 0.75 0.43-1.30 1.30 0.85-1.99
PDA: Patent ductus arteriosus; IVH: Intraventricular haemorrhage; c-PVL: Cystic
periventricular leukomalacia; NEC: Necrotizing enterocolitis; ROP: Retinopathy
of prematurity; BPD: Bronchopulmonary dysplasia.
1aORs indicate the association between AC and outcomes, adjusting for
gender, antenatal steroids, gestational age, SGA status (<10th BW percentile),
mode of delivery, region of birth, and mothers’ characteristics (age, country of
origin, education, and previous births).
2No estimation of the aORs was possible because no cases of c-PVL and NEC
were reported for AC singletons.
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more careful monitoring of mother and foetus conditions
[15,31]. It is also possible that pre-pregnancy health and
lifestyles of mothers determined to conceive and ultim-
ately accessing AC services are more favourable than in
naturally conceiving women and able to promote better
perinatal outcomes [32].
Indeed in our study women using AC, although older
than those who conceived naturally, did not seem to
have increased rates of pregnancy inflammation/infec-
tion or disorders of placentation that have been linked
with different patterns of placental pathologies and foetal/
neonatal outcomes [19,33,34]. They were also more likely
to be Italian and to have a higher education, and therefore
have access to the information and contacts that facilitate
healthier lifestyles and better health care.
We found that, compared to non-AC peers, AC multi-
ples had a lower risk of BPD, and this result persisted
after adjustment for PDA and mechanical ventilation,
two possible antecedents of BPD. Previous studies re-
ported inconclusive results about BPD. Schimmel et al.
found no difference in risk of chronic lung disease in
single and multiple VLBWI according to mode of con-
ception [12], while Picaud et al. reported a lower BPD
rates in infants <29 weeks gestation born after ART [15].
In contrast, Shah et al. found higher rates of BPD in
ART preterm multiples less than 33 weeks gestation
compared to naturally conceived peers [14].
These results are not directly comparable with ours
because of differences in study design (centre-basedrather than area-based) or eligibility criteria (birth
weight rather than gestational age). Other studies includ-
ing both preterm and at-term twins found better peri-
natal outcomes in ART- than in naturally conceived infants
[31,35]. Most unlikely these differences can be causally
linked to specific ART treatment effect. As already dis-
cussed, better pre-pregnancy health and perinatal care asso-
ciated with medically assisted reproduction may result in
offspring with more favourable clinical conditions.
This study has limitations. As in most studies focusing
on the special populations of very preterm or very low
birth weight infants (about 1-1.5% of total births), sam-
ple size may be not large enough to detect the neonatal
outcomes associated with AC. Also, we were not able to
separately investigate the risks of the different AC tech-
nologies, particularly those involving manipulation of
gametes outside the reproductive system, such as IVF
and ICSI. Nevertheless, the worse outcome in AC than
in non-AC singletons suggested by our findings, and the
reverse trend in multiple babies, is in agreement with
the worse outcomes in AC-conceived singletons re-
ported in recent meta-analyses [29,36].
The strengths of this study are the area-based pro-
spective design, thus averting selection biases caused by
a centre-based approach. Additionally, and unlike most
previous studies, recruitment was based on GA, which
prevented the bias arising when the birth weight criter-
ion is employed to study the relationship between ante-
natal and perinatal factors and neonatal outcomes.
Conclusion
In our population of newborn infants <32 weeks GA, al-
though a lower risk of some short-term outcomes, such
as PDA and BPD, was found in AC-multiples, we could
not demonstrate the presence or absence of different
risks of mortality and survival without major morbidities
in AC compared to non-AC conceived babies. A final
conclusion about differences of outcomes in VPI born
from assisted conception or naturally conceived cannot
therefore be reached. Although some of our results may
be of interest and suggest clues for clinical interpreta-
tions, larger and more powered studies are needed be-
fore confidently exclude the effects of AC on the short
term outcomes of very preterm infants. To this end, this
study can serve as a suitable pilot investigation.
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